Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for spinocerebellar ataxia type 10
RBR-36x4c4dPhase 1Completed
- Sponsor
- Universidade Federal do Paraná
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind, single-arm trial of cannabidiol in spinocerebellar ataxia type 10 (SCA10), sponsored by Universidade Federal do Paraná. Started Jul 2023; status: completed.
02
Drugs
cannabidiol
03
Conditions
spinocerebellar ataxia type 10 (SCA10)
Beyond the preview
Go deeper on RBR-36x4c4d.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-36x4c4d.